DK0558913T3 - System til pulseret indgivelse af minocyclin en gang daglig - Google Patents

System til pulseret indgivelse af minocyclin en gang daglig

Info

Publication number
DK0558913T3
DK0558913T3 DK93101096T DK93101096T DK0558913T3 DK 0558913 T3 DK0558913 T3 DK 0558913T3 DK 93101096 T DK93101096 T DK 93101096T DK 93101096 T DK93101096 T DK 93101096T DK 0558913 T3 DK0558913 T3 DK 0558913T3
Authority
DK
Denmark
Prior art keywords
minocycline
release
systems
medium
once daily
Prior art date
Application number
DK93101096T
Other languages
Danish (da)
English (en)
Inventor
Nitin Vadilal Sheth
Joseph James Valorose Jr
Keith Anthony Ellway
Madurai Gurusamy Ganesan
Keiran George Mooney
Jerry Bain Johnson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of DK0558913T3 publication Critical patent/DK0558913T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Magnetic Treatment Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Position Fixing By Use Of Radio Waves (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK93101096T 1992-03-02 1993-01-25 System til pulseret indgivelse af minocyclin en gang daglig DK0558913T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/844,109 US5262173A (en) 1992-03-02 1992-03-02 Pulsatile once-a-day delivery systems for minocycline

Publications (1)

Publication Number Publication Date
DK0558913T3 true DK0558913T3 (da) 1999-12-13

Family

ID=25291839

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93101096T DK0558913T3 (da) 1992-03-02 1993-01-25 System til pulseret indgivelse af minocyclin en gang daglig

Country Status (24)

Country Link
US (2) US5262173A (https=)
EP (1) EP0558913B1 (https=)
JP (1) JPH069407A (https=)
KR (1) KR100270491B1 (https=)
CN (1) CN1039194C (https=)
AT (1) ATE181504T1 (https=)
AU (1) AU656841B2 (https=)
CA (1) CA2090561C (https=)
CZ (1) CZ283684B6 (https=)
DE (1) DE69325402T2 (https=)
DK (1) DK0558913T3 (https=)
ES (1) ES2134221T3 (https=)
FI (1) FI110163B (https=)
GR (1) GR3031028T3 (https=)
HU (1) HU219580B (https=)
IL (1) IL104865A (https=)
LV (1) LV12399B (https=)
MX (1) MX9300998A (https=)
NO (1) NO307170B1 (https=)
NZ (1) NZ245951A (https=)
PL (1) PL171609B1 (https=)
SG (1) SG47785A1 (https=)
TW (1) TW299235B (https=)
ZA (1) ZA931444B (https=)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
ZA974359B (en) * 1996-05-23 1998-05-12 Zeneca Ltd Microencapsulated compositions.
US5932437A (en) * 1998-04-13 1999-08-03 Genesis Laboratories, Inc. Control of lyme disease spirochete
BR9914251A (pt) 1998-10-01 2001-06-19 Novartis Ag Formulações orais de liberação sustentada
JP2000119181A (ja) 1998-10-06 2000-04-25 Kureha Chem Ind Co Ltd エスクレチン及びその誘導体の放出制御経口製剤
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
EP1126826B3 (en) * 1998-11-02 2019-05-15 Alkermes Pharma Ireland Limited Multiparticulate modified release composition of methylphenidate
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
EP1165054A4 (en) * 1999-04-06 2005-02-09 Pharmaquest Ltd PHARMACEUTICAL DOSAGE FORM FOR INTERMITTENT DELIVERY OF METHYLPHENIDATE
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
AU764453B2 (en) 1999-10-29 2003-08-21 Euro-Celtique S.A. Controlled release hydrocodone formulations
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
JP2003527335A (ja) * 1999-10-29 2003-09-16 エフ エム シー コーポレーション 食用コーティング組成物
MXPA03003895A (es) 2000-10-30 2003-07-28 Euro Celtique Sa Formulaciones de hidrocodona de liberacion controlada.
IL155959A0 (en) 2000-11-28 2003-12-23 Fmc Corp Edible pga (propylene glycol alginate) coating composition
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP2311440A1 (en) * 2001-04-05 2011-04-20 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
WO2002100381A1 (en) * 2001-06-07 2002-12-19 Tanabe Seiyaku Co., Ltd. Functional grain-containing preparations quickly disintegrated in the oral cavity
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
ES2291749T5 (es) 2002-12-20 2011-07-21 F. Hoffmann-La Roche Ag Formulación de altas dosis de ibandronato.
WO2004091483A2 (en) * 2003-04-07 2004-10-28 Shire Laboratories, Inc. Once daily formulations of tetracyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
AU2006235483B2 (en) * 2005-04-12 2010-11-25 Elan Pharma International Limited Controlled release compositions comprising a cephalosporin for the treatment of a bacterial infection
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080318910A1 (en) * 2005-10-04 2008-12-25 Mistral Pharma, Inc. Controlled-Release Oral Dosage Form
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
PT103661B (pt) * 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
JP2010521494A (ja) * 2007-03-16 2010-06-24 エラン・ファルマ・インターナショナル・リミテッド 麻薬性および非麻薬性鎮痛剤の組み合わせ
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
SG185296A1 (en) 2007-10-12 2012-11-29 Takeda Pharmaceuticals Usa Inc Methods of treating gastrointestinal disorders independent of the intake of food
WO2010017310A1 (en) 2008-08-06 2010-02-11 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
EP2699236B1 (en) * 2011-04-22 2018-06-20 Napo Pharmaceuticals Inc Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
PT2704698T (pt) 2011-05-05 2019-11-19 Hennig Arzneimittel Gmbh&Co Kg Forma farmacêutica para a libertação controlada de princípios activos
DE102011075354A1 (de) * 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten Freigabe von Wirkstoffen
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
US11103517B2 (en) 2015-04-07 2021-08-31 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
CN108414466A (zh) * 2018-03-09 2018-08-17 浙江美华鼎昌医药科技有限公司 一种盐酸米诺环素缓释片体外溶出测定方法
EP3810114A4 (en) * 2018-04-30 2022-01-19 Melinta Therapeutics, Inc. METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL270408A (https=) * 1960-10-20
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation

Also Published As

Publication number Publication date
JPH069407A (ja) 1994-01-18
SG47785A1 (en) 1998-04-17
DE69325402D1 (de) 1999-07-29
KR100270491B1 (ko) 2000-11-01
IL104865A (en) 1997-02-18
PL171609B1 (pl) 1997-05-30
LV12399A (lv) 1999-12-20
PL297903A1 (en) 1993-11-15
EP0558913A1 (en) 1993-09-08
CN1039194C (zh) 1998-07-22
US5262173A (en) 1993-11-16
HUT64851A (en) 1994-03-28
DE69325402T2 (de) 2000-02-17
NO307170B1 (no) 2000-02-21
CN1078889A (zh) 1993-12-01
NZ245951A (en) 1994-06-27
ATE181504T1 (de) 1999-07-15
NO930743L (no) 1993-09-03
MX9300998A (es) 1993-09-01
KR930019209A (ko) 1993-10-18
CZ30093A3 (en) 1994-02-16
GR3031028T3 (en) 1999-12-31
HU219580B (hu) 2001-05-28
CA2090561A1 (en) 1993-09-03
ES2134221T3 (es) 1999-10-01
NO930743D0 (no) 1993-03-01
IL104865A0 (en) 1993-06-10
CZ283684B6 (cs) 1998-06-17
FI930906A0 (fi) 1993-03-01
AU3384293A (en) 1993-09-09
CA2090561C (en) 2004-10-05
ZA931444B (en) 1993-10-14
HU9300570D0 (en) 1993-05-28
AU656841B2 (en) 1995-02-16
FI110163B (fi) 2002-12-13
LV12399B (en) 2000-06-20
US5348748A (en) 1994-09-20
HK1009930A1 (en) 1999-06-11
TW299235B (https=) 1997-03-01
FI930906L (fi) 1993-09-03
EP0558913B1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
DK0558913T3 (da) System til pulseret indgivelse af minocyclin en gang daglig
CA2025703A1 (en) Pulsatile once-a-day delivery systems for minocycline
US4784858A (en) Controlled release tablet
IL119627A0 (en) Controlled-release pharmaceutical preparations
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
CA2098738A1 (en) Controlled Release Oxycodone Compositions
ATE217188T1 (de) Granulierte pharmazeutische zusammensetzung
ATE319431T1 (de) Pharmazeutische zusammensetzung mit gesteuerter freigabe und verzögerter absorption
ZA912793B (en) Pharmaceutical formulations
CA2383212C (en) Controlled release oral dosage suitable for oral administration
CA2180178A1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
MY137570A (en) Method for the preparation of a pharmaceutical composition comprising 5-aminosalicyclic acid for use in treatment of ulcerative colitis crohn's disease
NL8702297A (nl) Medicament voor het verschaffen van fluoride-ionen voor de behandeling en preventie van met botverlies gepaardgaande ziekten.
ATE212550T1 (de) Tiagabinhaltige arzneizubereitungen mit gesteuerter wirkstoffverabreichung
Percy et al. Pharmacokinetics of tetracycline in the domestic rabbit following intravenous or oral administration
CA2356306A1 (en) Sulfated phosphatidylinositols, their preparation and use
US6129931A (en) Controlled-release, drug-delivery tableted composition including a complex between poly(maleic diacid-alkyl vinyl ether) and polyvinylpyrrolidone
MY110769A (en) Controlled release oxycodone compositions.
CA2187153A1 (en) Effervescent pharmaceutical formulations containing controlled release biodegradable microcapsules
MY114610A (en) Controlled drug delivery system for diltiazem.
CZ5821U1 (cs) Farmaceutický přípravek pro léčení hernofilie a použití hormonu mestranolu
RU97115937A (ru) Применение изосорбид-5-мононитрата